[1] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo, Japan
[2] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi, Japan
[3] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Ctr Epidemiol Studies & Clin Trials,Shanghai Inst, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Ctr Vasc Evaluat,Shanghai Inst Hypertens, Shanghai, Peoples R China
[5] Univ Calif Irvine, Sch Med, Div Cardiol, Heart Dis Prevent Program, Irvine, CA 92717 USA
[6] Univ Leuven, KU Leuven, Dept Cardiovasc Sci, Studies Coordinating Ctr,Res Unit Hypertens & Car, Campus Sint Rafael,Kapucijnenvoer 35, BE-3000 Leuven, Belgium
[7] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland
[8] Maastricht Univ, R&D Grp VitaK, Maastricht, Netherlands